跳至主要内容
临床试验/NCT03403530
NCT03403530已完成4 期

A Prospective Study to Analyze the Efficacy of IgM Rich Immunoglobulin as an Adjunct to Antibiotics in the Treatment of Bacterial Sepsis in Very Low Birth Weight Preterm Neonates

Sir Takhtasinhji General Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年1月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Discharge rates

研究概览

简要总结

Study comprises of giving IVIG to half of the septic VLBW preterm neonates along with ongoing antibiotics and placebo to the other half. The immunoglobulin will be given for 3 days and neonates will be monitored for the results. The data will be analysed on the basis of blood culture results and outcome of the patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
1 Day 至 30 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Very low birth weight baby: birth weight 1-1.5 kg
  • Both inside and outside delivered babies
  • Gender: males and females
  • Probable severe sepsis (septic score)

排除标准

  • Extremely low birth weight babies: < 1 kg
  • Babies >1.5 kg birth weight
  • Babies born with congenital malformations
  • Full term babies
  • IUGR babies
  • Child with no signs of sepsis
  • HBsAg Positive
  • HIV Positive

研究组 & 干预措施

case group

Active Comparator

'IgM rich immunoglobulin' intravenous infusion in the dose of 5 ml/ kg/ dose over 3 hours once a day for 3 days.

干预措施: IgM rich Immunoglobin (Drug)

control group

Placebo Comparator

antibiotics only

干预措施: IgM rich Immunoglobin (Drug)

结局指标

主要结局

Discharge rates

时间窗: 6 months

patients who received IgM rich Immunoglobin along with antibiotics have better outcome as compared to the patients who receive only antibiotics.

次要结局

  • Duration of hospital stay(6 months)

研究者

发起方
Sir Takhtasinhji General Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Sonal V Jindal

Principal Investigator, Resident

Sir Takhtasinhji General Hospital

研究点 (1)

Loading locations...

相似试验